Liver stiffness in young people with glycogen storage disease type III
Part of Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at liver stiffness (a sign of scarring, called fibrosis) in children and young adults with type III glycogen storage disease. Researchers want to see how common liver fibrosis is in this group and how it changes over time, using a non-invasive ultrasound-like test called elastography.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 21 years old (minor or young adult)
- You have been diagnosed with type III glycogen storage disease (GSD III)
- You have had at least one liver elastography test (a special ultrasound that checks liver stiffness) during your regular checkups
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This study tests a new wearable patch that uses ultrasound to measure liver stiffness without needing a permanent probe. It could be a more comfortable and convenient way to check your liver health, and results will be compared to the standard FibroScan test.
This study uses a special ultrasound to measure how stiff your liver is, which can help doctors understand liver failure better. If you have serious liver problems, this test might help guide your care.
This study uses a special ultrasound technique to measure how much scarring (fibrosis) has built up in the liver of children with cholestatic liver disease. The goal is to see if this non-invasive method can assess the degree of liver damage without needing a biopsy.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This study tracks the health of people with type 3 Glycogen storage disease. It may help doctors understand the disease better and plan better care.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.